1. Insights
  2. News
  3. Press Releases

Akin Advises Pharmakon Advisors in $200 Million Commitment to Tarsus Pharmaceuticals

April 24, 2024

Reading Time : 1 min
Jump to
View People Mentioned in This NewsView Related Services, Sectors, and Regions

Contact:

Jacinta O'Shea-Ramdeholl

Director of Communications

Send Email
+1 212.407.3080

Scott Wasserman

Senior Media Relations Manager

Send Email
+1 212.407.3009

(New York) – Akin advised Pharmakon Advisors, LP and its affiliated funds in a $200 million senior secured credit facility to Tarsus Pharmaceuticals, Inc., whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care.

The Akin team was led by tax partner Geoffrey Secol, and included international trade partner Nnedinma Ifudu Nweke, tax partner David Snyder, senior counsel Jo-Ellyn Klein, counsel Sudhana Bajracharya and Ekaterina Lyashenko and associates Jake Gawlak and Angela Sbano.

Further details on the transaction can be found here.

Akin is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.

# # #

Share This Insight

Related Services, Sectors, and Regions

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.